🇮🇳IN
Sign In
IP

IPCALAB

NSE

Ipca Laboratories Ltd

₹1,953.30

+49.80(+2.62%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

IPCALAB financial summary

For Mar 2026, Ipca Laboratories Ltd reported revenue of ₹7,289 crore, which grew 9.9% from the previous year. Net profit was ₹1,133 crore, which grew 74.0% year on year, on an operating margin of 24%. Earnings per share came in at ₹44.64. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹7,289 crore
Net profit₹1,133 crore
Operating margin24%
EPS₹44.64

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer